Literature DB >> 4018394

Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum.

S I Ymer, A C Herington.   

Abstract

The binding in vitro of 125I-human or bovine growth hormone (GH) to normal female rabbit serum has been studied using gel filtration to separate bound and free hormone. On Ultrogel AcA34 columns, a substantial peak of specific 125I-GH binding was observed at a MW approximately 120 000. This peak was not precipitable by 12.5% polyethylene glycol, a method used widely for solubilized hormone receptors. Assuming a 1:1 binding stoichiometry between GH (MW 21 000) and the binding protein, the MW of the binding protein would be approximately 100 000. Gel filtration of serum alone, followed by assessment of 125I-hGH binding in column fractions, indicated the binding protein had a similar MW (83 000-107 000). Specific binding of 125I-hGH was dependent on incubation time (equilibrium being reached in 2 h at 21 degrees C), Ca2+ concentration (0.5-2.0 mM) and serum concentration (a 1:5 dilution of serum giving 45.2 +/- 1.7% specific binding; mean +/- SE, n = 10). Binding was completely reversible (t 1/2 approximately 1.5 h) and specific for somatotrophic but not lactogenic hormones. Scatchard analysis revealed linear plots with a Ka 1.59 +/- 0.11 X 10(9) M-1 and capacity 3700 fmol/ml serum. The presence in rabbit serum of a high affinity, GH-specific, binding protein raises important questions regarding its identity and possible physiological role in modulating the delivery and/or activity of GH in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018394     DOI: 10.1016/0303-7207(85)90018-8

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

1.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Monoclonal antibodies to the pituitary growth-hormone receptor by the anti-idiotypic approach. Production and initial characterization.

Authors:  M I Elbashir; T Brodin; B Akerström; J Donnér
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

3.  Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane 'receptor' types 1 and 2.

Authors:  R Barnard; M J Waters
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

Review 4.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

5.  Growth hormone secretion in children and adolescents with familial tall stature.

Authors:  M Tauber; C Pienkowski; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

6.  Structural studies on membrane-bound and soluble growth-hormone-binding proteins of rabbit liver.

Authors:  S I Ymer; A C Herington
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

7.  Pharmacokinetics of radioiodinated human and ovine growth hormones in transgenic mice expressing bovine growth hormone.

Authors:  D Turyn; A Bartke
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

8.  Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

Authors:  W H Daughaday; B Trivedi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Massa; L Dooms; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

10.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.